logo
Plus   Neg
Share
Email

Stock Alert: Fulgent Genetics Up 20% On COVID-19 Testing Deal For NY Schools

Shares of Fulgent Genetics Inc. (FLGT) are currently gaining nearly 20% on Thursday morning. The other day, the genetic testing services company said it would supply COVID-19 testing to hundreds of thousands of students in collaboration with New York City Health and Hospitals at nearly 1,600 locations.

FLGT is currently trading at $34.52, up $6.14 or 21.28%, on the Nasdaq.

The California-based company will supply its RT-PCR at-home test, approved under US FDA emergency use authorization, for students, as they return to school beginning September.

Separately, Fulgent also announced that beginning September 28th, all patients tested for COVID-19 by Fulgent Genetics will also receive results for Influenzas A and B.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Macy's is offering a sneak peek of its Black Friday deals for this year, so that shoppers can get a head start on finding some of the best deals. The department store has unveiled its Black Friday deals that will be available next month across categories, including fashion, fine jewelry, tech, beauty, toys and home specials. Some of the deals will be available for as low as $5. Italy's antitrust watchdog has opened an investigation against Google for an alleged abuse of dominant position in the Italian market for display advertising. This refers to the space publishers and website owners make available for the display of advertising content. Shares of Deutsche Bank AG were gaining around 3 percent in German trading after the banking major reported Wednesday a profit in its third quarter, compared to prior year's loss mainly driven by strong Investment Bank revenues. Looking ahead, the bank said it remains on track to meet all financial and strategic targets related to its transformation plan.
Follow RTT